Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03153501
Other study ID # PR-11-01-31-21
Secondary ID
Status Completed
Phase N/A
First received May 4, 2017
Last updated May 12, 2017
Start date February 8, 2011
Est. completion date April 30, 2017

Study information

Verified date May 2017
Source Eskisehir Osmangazi University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Image-guided pleural biopsies, both ultrasound (US) or computed tomography (CT) guided, and medical thoracoscopy are important in the diagnosis of pleural disease. However, no consensus exists regarding which biopsy methods are appropriate for specific procedures.

In this prospective study, the investigators aimed to compare CT-scan guided pleural biopsy using an Abrams' needle (CT-ANPB) with US-assisted pleural biopsy using a cutting needle (US-CNPB)and medical thoracoscopy with respect to both diagnostic yield and safety.


Description:

The primary end point of this study was the determination of the sensitivity and the complication rates of the invasive methods, Abrams needle pleural biopsy, tru-cut needle pleural biopsy, medical thoracoscopy with respect to the diagnosis of pleural disease.


Recruitment information / eligibility

Status Completed
Enrollment 164
Est. completion date April 30, 2017
Est. primary completion date February 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Patients with pleural diseases

Exclusion Criteria:

- Patients with other lung diseases

Study Design


Intervention

Diagnostic Test:
CT-guided Abrams needle biopsy, US-guided cutting needle, medical thoracoscopy


Locations

Country Name City State
Turkey Eskisehir Osmangazi University Medical Faculty Eskisehir
Turkey ESOGU Medical Faculty Department of Chest Diseases Eskisehir Meselik - Eskisehir

Sponsors (1)

Lead Sponsor Collaborator
Eskisehir Osmangazi University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Kim SJ, Choi SM, Lee J, Lee CH, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Park YS. Medical Thoracoscopy in Pleural Disease: Experience from a One-Center Study. Tuberc Respir Dis (Seoul). 2017 Apr;80(2):194-200. doi: 10.4046/trd.2017.80.2.194. Epub 2017 Mar 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic efficiencies of pleural biopsy methods; CT-guided Abrams needle, US-guided cutting needle and medical thoracoscopy in the diagnosis of pleural diseases: The sensitivity, specificity, negative predictive value and positive predictive value. The sensitivity, specificity, negative predictive value and positive predictive value of computed tomography guided Abrams needle pleural biopsy, ultrasonography guided cutting needle biopsy and medical thoracoscopy techniques in the diagnosis of pleural diseases. 5 years
Primary Safety of pleural biopsy methods; CT-guided Abrams needle, US-guided cutting needle and medical thoracoscopy in the diagnosis of pleural diseases: Rate of side effects. Rate of side effects comparing to each other for computed tomography guided Abrams needle pleural biopsy, ultrasonography guided cutting needle biopsy and medical thoracoscopy techniques in the diagnosis of pleural diseases. 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT06159179 - Medical Thoracoscopy for Undiagnosed Transudative and Exudative Pleural Effusion N/A
Active, not recruiting NCT05430308 - Surgical Site Preparation in Subjects Undergoing Medical Thoracoscopy N/A